DOES FINERENONE (KERENDIA) REDUCE HEART FAILURE EVENTS IN PEOPLE WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)?
Prefer to listen? Check out my podcast here! As blogged previously, finerenone (brand name...
Read Moreby Dr. Sue Pedersen | Sep 15, 2024 | Research, Uncategorized | 0
Prefer to listen? Check out my podcast here! As blogged previously, finerenone (brand name...
Read Moreby Dr. Sue Pedersen | Jun 27, 2024 | Research, Uncategorized | 0
Prefer to listen? Check out my podcast here! Obstructive sleep apnea (OSA) is a common condition...
Read Moreby Dr. Sue Pedersen | May 26, 2024 | Diabetes, Research, Uncategorized | 0
Prefer to listen? Check out my podcast here! We know that GLP1 receptor agonists have many health...
Read Moreby Dr. Sue Pedersen | Apr 13, 2024 | Diabetes, Research, Uncategorized | 0
Prefer to listen? Check out my podcast here! As blogged previously, semaglutide 2.4mg (Wegovy) has...
Read Moreby Dr. Sue Pedersen | Feb 12, 2024 | Research, Uncategorized | 0
Prefer to listen? Check out my podcast here! As blogged previously, innovative new weight...
Read Moreby Dr. Sue Pedersen | Dec 21, 2023 | Diabetes, Research, Uncategorized | 0
Prefer to listen? Check out my audio recording of this post here: Insulin (used to treat diabetes)...
Read Moreby Dr. Sue Pedersen | Nov 12, 2023 | Media, Research | 0
NEW ON DRSUE.CA! Prefer to listen? Check out my audio recording of this post here: After much...
Read Moreby Dr. Sue Pedersen | Nov 9, 2023 | Diabetes, Research, Uncategorized | 0
NEW ON DRSUE.CA! Prefer to listen? Check out my audio recording of this post here: It is...
Read Moreby Dr. Sue Pedersen | Aug 28, 2023 | Research, Uncategorized | 0
Heart failure is a known health complication that can occur in people with elevated weight. As...
Read Moreby Dr. Sue Pedersen | Aug 9, 2023 | Media, Research, Uncategorized | 0
People who carry excess body weight have an increased risk of cardiovascular disease. Thus, one...
Read Moreby Dr. Sue Pedersen | Jul 14, 2023 | Research, Uncategorized | 0
As blogged previously, existing data suggests that GLP1 receptor agonists (GLP1RAs) may protect...
Read Moreby Dr. Sue Pedersen | Jun 29, 2023 | Diabetes, Media, Research, Uncategorized | 0
This year’s American Diabetes Association (ADA) meeting has concluded, leaving...
Read MoreI am a medical doctor, Specialist in Endocrinology & Metabolism, a Diplomate of the American Board of Obesity Medicine, and a Clinical Lecturer at the University of Calgary, Canada. After completing my training as an Endocrinologist in 2005 at the University of Calgary, I have worked in Calgary, at the Royal University Hospital in Saskatchewan, and at the University of Copenhagen in Denmark. I have a busy clinical practice at C-ENDO Diabetes and Endocrinology Clinic in Calgary, caring for patients with diabetes, obesity, thyroid, and other hormone issues. I am also involved in clinical research in diabetes and obesity. I am the lead author of the 2020 and 2022 Pharmacotherapy Chapters of the Canadian Obesity Clinical Practice Guidelines, and a member of the Expert Committee for the Diabetes Canada Clinical Practice Guidelines as an author on the Weight Management chapter. I am passionate, enthusiastic, and driven to help conquer the stigma against obesity; educate health care professionals and the public about obesity and diabetes; and to help us become a healthier society!